Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn

C. Ambrus,J. L. Ambrus,N. Courey,L. Mosovich,E. Bruck,J. Allen,Okhee Jung,E. Mirand,K. Niswander
DOI: https://doi.org/10.1002/ajh.2830070307
1979-11-01
Abstract:Late diabetic complications are often related to vascular changes and formation of thrombi in the altered vasculature. Contributing factors to thrombosis susceptibility of diabetic patients include changes in clotting factors, platelets, and inhibition of fibrinolysis. We have measured various fibrinolytic inhibitors in the blood of diabetic children, diabetic pregnant women and their offspring, and healthy controls. Inhibitors studied included 1) fast (immediate) antiplasmin, 2) slow (progressive) antiplasmin, 3) alpha‐2‐macroglobulin, and 4) alpha‐1‐antitrypsin.
What problem does this paper attempt to address?